These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 17224890)

  • 21. Glycoprotein IIb/IIIa receptor inhibition with abciximab during percutaneous coronary interventions increases the risk of bleeding in patients with impaired renal function.
    Pinkau T; Ndrepepa G; Kastrati A; Mann JF; Schulz S; Mehilli J; Schömig A
    Cardiology; 2008; 111(4):247-53. PubMed ID: 18434733
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of severity of renal dysfunction on determinants of in-hospital mortality among patients undergoing percutaneous coronary intervention.
    Parikh PB; Jeremias A; Naidu SS; Brener SJ; Lima F; Shlofmitz RA; Pappas T; Marzo KP; Gruberg L
    Catheter Cardiovasc Interv; 2012 Sep; 80(3):352-7. PubMed ID: 22566286
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Short and long term outcome of percutaneous coronary intervention with drug eluting stent and bare metal stent in patients with chronic kidney disease.
    Resmini C; Di Cuia M; Ballocca F; D'Ascenzo F; Bollati M; Moretti C; Omedè PL; Sciuto F; Gaita F; Sheiban I
    Minerva Cardioangiol; 2012 Dec; 60(6):573-80. PubMed ID: 23147435
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A randomised determination of the Effect of Fluvastatin and Atorvastatin on top of dual antiplatelet treatment on platelet aggregation after implantation of coronary drug-eluting stents. The EFA-Trial.
    Wenaweser P; Eshtehardi P; Abrecht L; Zwahlen M; Schmidlin K; Windecker S; Meier B; Haeberli A; Hess OM
    Thromb Haemost; 2010 Sep; 104(3):554-62. PubMed ID: 20664903
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Outcome in elderly patients undergoing primary coronary intervention for acute myocardial infarction: results from the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) trial.
    Guagliumi G; Stone GW; Cox DA; Stuckey T; Tcheng JE; Turco M; Musumeci G; Griffin JJ; Lansky AJ; Mehran R; Grines CL; Garcia E
    Circulation; 2004 Sep; 110(12):1598-604. PubMed ID: 15353506
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects on mortality of abciximab in ST-elevation myocardial infarction treated with percutaneous coronary intervention including stent implantation.
    Tornvall P; Nilsson T; Lagerqvist B
    J Intern Med; 2006 Oct; 260(4):363-8. PubMed ID: 16961673
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 3-year follow-up of 100 consecutive coronary bifurcation lesions treated with Taxus stents and the crush technique.
    Chue CD; Routledge HC; Ludman PF; Townend JN; Epstein AC; Buller NP; Doshi SN
    Catheter Cardiovasc Interv; 2010 Mar; 75(4):605-13. PubMed ID: 20066725
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of anemia in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention: analysis from the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) Trial.
    Nikolsky E; Aymong ED; Halkin A; Grines CL; Cox DA; Garcia E; Mehran R; Tcheng JE; Griffin JJ; Guagliumi G; Stuckey T; Turco M; Cohen DA; Negoita M; Lansky AJ; Stone GW
    J Am Coll Cardiol; 2004 Aug; 44(3):547-53. PubMed ID: 15358018
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Results of the U.S. ARRIVE 1 registry: 2-year outcomes.
    Kornowski R
    Catheter Cardiovasc Interv; 2008 Oct; 72(4):446-7. PubMed ID: 18819146
    [No Abstract]   [Full Text] [Related]  

  • 30. Towards a tailored use of eluted drugs for percutaneous coronary interventions.
    Zimarino M; Ruggieri B; De Caterina R
    Circ J; 2010 Mar; 74(3):424-5. PubMed ID: 20145336
    [No Abstract]   [Full Text] [Related]  

  • 31. Management of coronary atherosclerosis and acute coronary syndromes in patients with chronic kidney disease.
    Narala KR; Hassan S; LaLonde TA; McCullough PA
    Curr Probl Cardiol; 2013 May; 38(5):165-206. PubMed ID: 23590761
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Current perspectives on interventional treatment strategies in diabetic patients with coronary artery disease.
    Kornowski R; Lansky AJ
    Catheter Cardiovasc Interv; 2000 Jun; 50(2):245-54. PubMed ID: 10842400
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Highlights from Transcatheter Cardiovascular Therapeutics 2009: San Francisco, California, September 21 to 25, 2009.
    Sparling JM; Resnic FS
    J Thorac Cardiovasc Surg; 2010 Feb; 139(2):515-7. PubMed ID: 20106412
    [No Abstract]   [Full Text] [Related]  

  • 34. Evidence based management of patients undergoing PCI. Conclusion.
    Lasala JM; Mehran R; Moses JW; Popma JJ; Reiner JS; Sharma SK; Vetrovec GW
    Catheter Cardiovasc Interv; 2010 Mar; 75 Suppl 1():S43-5. PubMed ID: 20333707
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 'FREEDOM' trial: have the interventional cardiologists lost their freedom?
    Jariwala P; Chandra S
    Indian Heart J; 2013; 65(1):114-6. PubMed ID: 23438627
    [No Abstract]   [Full Text] [Related]  

  • 36. Here today, gone today: time for same-day discharge after PCI.
    Blankenship JC
    Catheter Cardiovasc Interv; 2008 Nov; 72(5):626-8. PubMed ID: 18949777
    [No Abstract]   [Full Text] [Related]  

  • 37. Cardiovascular disease in patients with chronic kidney disease.
    Pilmore H; Dogra G; Roberts M; Lambers Heerspink HJ; Ninomiya T; Huxley R; Perkovic V
    Nephrology (Carlton); 2014 Jan; 19(1):3-10. PubMed ID: 23927055
    [No Abstract]   [Full Text] [Related]  

  • 38. Percutaneous revascularization of coronary chronic total occlusions: the new era begins.
    Thompson CA
    JACC Cardiovasc Interv; 2010 Feb; 3(2):152-4. PubMed ID: 20170871
    [No Abstract]   [Full Text] [Related]  

  • 39. Cardiovascular disease in chronic kidney disease: risk factors, pathogenesis, and prevention.
    Ardhanari S; Alpert MA; Aggarwal K
    Adv Perit Dial; 2014; 30():40-53. PubMed ID: 25338421
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treating coronary artery disease in diabetic patients with balloons and stainless steel: what is the role of percutaneous coronary intervention?
    Murphy JG; Allison TG
    Mayo Clin Proc; 2013 Jan; 88(1):4-6. PubMed ID: 23274014
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.